DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 173 filers reported holding DENALI THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $24,000 | -17.2% | 800 | -12.1% | 0.01% | 0.0% |
Q1 2022 | $29,000 | -19.4% | 910 | +12.2% | 0.01% | -16.7% |
Q4 2021 | $36,000 | +100.0% | 811 | +125.3% | 0.01% | +100.0% |
Q3 2021 | $18,000 | -41.9% | 360 | -9.8% | 0.00% | -50.0% |
Q2 2021 | $31,000 | +55.0% | 399 | +14.0% | 0.01% | +20.0% |
Q1 2021 | $20,000 | -31.0% | 350 | 0.0% | 0.01% | -28.6% |
Q4 2020 | $29,000 | +61.1% | 350 | -30.0% | 0.01% | +16.7% |
Q3 2020 | $18,000 | -78.8% | 500 | -85.7% | 0.01% | -81.8% |
Q2 2020 | $85,000 | -3.4% | 3,500 | -30.0% | 0.03% | -17.5% |
Q1 2020 | $88,000 | +3.5% | 5,000 | +2.0% | 0.04% | +25.0% |
Q4 2019 | $85,000 | +466.7% | 4,900 | +390.0% | 0.03% | +357.1% |
Q3 2019 | $15,000 | -25.0% | 1,000 | 0.0% | 0.01% | -22.2% |
Q2 2019 | $20,000 | -4.8% | 1,000 | 0.0% | 0.01% | -18.2% |
Q1 2019 | $21,000 | -97.7% | 1,000 | -97.7% | 0.01% | -98.1% |
Q4 2018 | $899,000 | -7.0% | 43,518 | -5.1% | 0.59% | +2.6% |
Q3 2018 | $967,000 | +16.8% | 45,838 | -15.6% | 0.58% | -34.8% |
Q2 2018 | $828,000 | -11.1% | 54,305 | +9.4% | 0.88% | +28.4% |
Q1 2018 | $931,000 | – | 49,642 | – | 0.69% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 5,960,732 | $122,969,901 | 14.32% |
ARCH Venture Management, LLC | 693,749 | $14,312,042 | 9.30% |
Flagship Pioneering Inc. | 2,619,968 | $54,049,940 | 3.92% |
Casdin Capital, LLC | 1,300,000 | $26,819,000 | 2.97% |
Yiheng Capital Management, L.P. | 1,150,684 | $23,738,611 | 1.21% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 154,000 | $3,172,400 | 1.07% |
SECTORAL ASSET MANAGEMENT INC | 254,941 | $5,259,433 | 1.02% |
Temasek Holdings (Private) Ltd | 6,895,992 | $142,264,315 | 0.85% |
Clarius Group, LLC | 378,262 | $7,803,545 | 0.74% |
Artal Group S.A. | 802,899 | $16,564 | 0.71% |